Posted in Abbott, Amgen, AstraZeneca, BMS, Bayer, Biotech, Celgene, Daiichi Sankyo, FDA, Forest Labs, GSK, Genentech, J&J, Johnson and Johnson, Lilly, Medical Devices, Medicine, Merck, Novartis, Pfizer, Pharma, Pharma News, Pharmaceutical, Red Cross, Sales training, Sanofi-Aventis, Statins, Takeda, tagged alimta, asco, Avastin, herceptin, Millennium, psoriasis, rad001, ranbaxy, s, trasylol, vaptan, vectibix, viagra, xience, zometa on May 16, 2008 | No Comments »
There’s a ton of stuff going on this week, plus we’re in pre-ASCO mode (so lots of oncology news - scroll down for those headlines). Here we go:
What’s a vaptan? Maybe something pretty exciting - A new class of drugs called vaptans may be able to treat a wide variety of conditions including painful periods, [...]
Read Full Post »
Having so enjoyed reviewing Genentech’s website, I thought I’d investigate the home page of another major West Coast biotech - Amgen.
In the first few seconds, things looked encouraging. Nice graphic background, some use of Flash overlays, a simple and appealing blue and white theme. But then it started - Linkapalooza.
The navigational elements were suddenly sprinkled [...]
Read Full Post »
Posted in Amgen, GSK, Glaxosmithkline, Healthcare, J&J, Johnson and Johnson, Lilly, Medicine, Merck, News, Novartis, Pharma, Pharma News, Pharmaceutical, Sales, Wyeth, tagged femara, prezista, promacta, zevaliln on March 17, 2008 | 1 Comment »
Pharma Sales reps - what rewards do they most prefer?
Pharma Sales reps - gift-giving ban in Massachusetts coming? Plus, a summary from Med Ad News on the growing number of academic medical centers banning pharma sales reps entirely.
Pharma Sales reps - don’t delete documents!
Amgen gets a slap on the use of EPO for cancer, but [...]
Read Full Post »
Posted in Amgen, Daiichi Sankyo, Genentech, Lilly, Medical Devices, Medicine, Novartis, Pfizer, Pharma, Pharma News, Pharmaceutical, Statins, Wyeth, tagged Avastin, Baxter, heparin, Rituxan, Sutent, Xyntha on February 23, 2008 | No Comments »
Novartis Pharma US CEO Alex Gorsky resigns.
Genentech’s Avastin and breast cancer - meets study goals, gets approved.
Heparin investigation gets ugly for Baxter. If you click on the link in the 2nd paragraph to look at the pictures of manufacturing in China, do so well before your next meal…uggh.
New treatment for Hemophilia A - Wyeth’s Xyntha [...]
Read Full Post »
Posted in Amgen, Bayer, J&J, Johnson and Johnson, Medicine, Merck, Novartis, Pharma, Pharma News, Pharmaceutical, Roche, Sanofi-Aventis, Schering, Takeda on August 30, 2007 | No Comments »
On the Oncology front…
Bayer’s Nexavar shows encouraging results: Bayer and Onyx Pharmaceuticals said they were stopping a late clinical liver cancer trial with Nexavar in the Asia-Pacific region so patients can get the drug sooner after encouraging results…more
Vaccinating against other cancers? Should boys get the vaccine that prevents cervical cancer in women? Maybe, a new [...]
Read Full Post »
Posted in Amgen, Biotech, GSK, Glaxosmithkline, J&J, Johnson and Johnson, Novartis, Oncology, Pharma, Pharma News, Pharmaceutical, Red Cross, Takeda on August 17, 2007 | No Comments »
Amgen finally feels the heat from declining market demand; big cuts coming.
Novartis takes a hit on Prexige (COX-2 inhibitor); withdrawn in Australia.
New cancer killers? Electric fields, gene switch. Cool emerging research.
Very lean little biotech (Koronis) pursues a new approach to combating HIV.
GSK and Takeda have to add black box warnings to Avandia and Actos.
J&J taking [...]
Read Full Post »
